Weekly curated updates on drug launches, global approvals, and pharma R&D developments
November 29, 2025
NEC, JFCR & Taiho to Develop Shared-Neoantigen Cancer Vaccines
NEC, together with the Japan Cancer Research Institute (JFCR) and Taiho Pharmaceutical, publicized a partnership to crea...
Read Full StoryNovember 29, 2025
FDA Approves Otsuka’s Voyxact for IgA Nephropathy (IgAN)
Otsuka's monoclonal antibody Voyxact has received FDA approval for the treatment of primary IgA nephropathy (IgAN) i...
Read Full StoryNovember 29, 2025
FDA Approves Durvalumab (Imfinzi) + FLOT Regimen for Resectable Gastric & GEJ Cancer
The U.S. FDA has given the green light to AstraZeneca’s durvalumab (Imfinzi) in combination with the FLOT chemothe...
Read Full StoryNovember 29, 2025
FDA Approves Novartis Gene Therapy Itvisma for Spinal Muscular Atrophy (SMA)
The U.S. FDA has granted Novartis' gene therapy Itvisma approval for the treatment of spinal muscular atrophy (SMA)...
Read Full StoryNovember 20, 2025
EMA CHMP Recommends 10 New Medicines for Approval
During its meeting from November 10 to 13 in the year 2025, the EMA-CHMP gave out a positive opinion which proposed the...
Read Full Story